e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Measuring the effects of treatment in patients with PAH: should we image the right ventricle?
Andrew J. Peacock
Source:
Eur Respir J, 49 (6) 1700805; 10.1183/13993003.00805-2017
Journal Issue:
June
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Andrew J. Peacock. Measuring the effects of treatment in patients with PAH: should we image the right ventricle?. Eur Respir J, 49 (6) 1700805; 10.1183/13993003.00805-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Treatment of right heart failure on pulmonary arterial hypertension: is going left a step in the right direction?
Source: Eur Respir Rev 2009; 19: 4-6
Year: 2010
MRI derived left atrial volume index predicts treatment response in patients with PAH
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016
Left and right ventricular function in patients with end-stage idiopathic pulmonary fibrosis. Which ventricle is most affected?
Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems
Year: 2009
Imaging the right ventricle: what can we learn?
Source: Annual Congress 2009 - The pulmonologist and the right ventricle
Year: 2009
Echocardiographic parameters of right ventricular dysfunction in pulmonary hypertension. Usefulness of speckle tracking longitudinal strain of the right ventricle
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010
Case 2: Is it left ventricular dysfunction or PAH?
Source: International Congress 2017 – CC6 Is it truly pulmonary arterial hypertension?
Year: 2017
Can right ventricle imaging improve risk stratification in pulmonary arterial hypertension?
Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management
Year: 2021
Late Breaking Abstract - Right heart structural changes, exercise capacity and stress induced right ventricle dysfunction in non- severe COPD patients without pulmonary hypertension at rest.
Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD
Year: 2018
The consequence of pulmonary hypertension on the right ventricle: physiological concepts
Source: Annual Congress 2011 - The burden of pulmonary hypertension in respiratory disease
Year: 2011
Right ventricular mechanical efficiency measured in PAH patients using PET
Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension
Year: 2009
Improvements in the dysfunctional right ventricle with Macitentan treatment in a sugen/hypoxic rat model of pulmonary hypertension
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020
REPAIR: long-term effects of macitentan on the right ventricle (RV) in pulmonary arterial hypertension (PAH)
Source: Virtual Congress 2020 – Updated assessment and treatment of pulmonary arterial hypertension
Year: 2020
Evaluation of pulmonary hypertension by right heart catheterisation: does timing matter?
Source: Eur Respir J, 56 (3) 1901892; 10.1183/13993003.01892-2019
Year: 2020
Are we selecting the right inhaler for the right COPD patient?
Source: Virtual Congress 2021 – Part I: restarting COPD care in the post-COVID era
Year: 2021
Cardiac MRI right atrial area measurement thresholds for risk stratification in patients with PAH
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020
Measuring health in pulmonary hypertension: emphasising the right end-point?
Source: Eur Respir J 2014; 43: 960-962
Year: 2014
Macitentan treatment improves the dysfunctional right ventricle in a sugen/hypoxic rat model of pulmonary hypertension
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019
Right ventricular global strain and right ventricular dyssynchrony can predict success to pulmonary vasodilators therapy in PH patients
Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept